Feature | Cath Lab | September 14, 2016

VIVA Announces Late-Breaking Clinical Trial Presentations

VIVA 2016, late breaking trials, cath lab

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular interventions. All trials represent data never before presented and are of global significance to physicians and others interested in the rapid advancement of therapies for vascular diseases. The meeting is Sept. 18-22, in Las Vegas, Nev.

Presentations Monday, Sept. 19 

8:31 AM — MOBILE Clinical Trial: MarrOwStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) — Michael P. Murphy, M.D., FACS

8:43 AM — Safety and Performance of the Shockwave Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: Six-Month Results from the Two-phase DISRUPT PAD Study — Thomas Zeller, M.D.

8:55 AM — Results from the IN.PACT SFA Randomized Trial — Prakash Krishnan, M.D.

9:07 AM — VIRTUS US Iliofemoral Stenting IDE Trial  — Stephen Black, M.D.

9:19 AM — Drug-Coated Balloon Treatment for Patients With Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort — Michael R. Jaff, D.O.   

 

Presentations Tuesday, Sept. 20 

8:10 AM — Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study — Ali Azizzadeh, M.D.  

8:22 AM — Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry — Zvonimir Krajcer, M.D.      

8:34 AM — Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach — Charmaine Lok, M.D., FRCPC        

8:46 AM — MAJESTIC 2 Year Results Plus Sub-group Analysis —Stefan Müller-Hülsbeck, M.D.

8:59 AM — 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study — Antonio Micari, M.D., Ph.D.    

 

Presentations Wednesday, Sept. 21

9:10 AM — ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries — Richard Rapoza, M.D.  

9:22 AM — 12 Month Results from the DANCE Trial Atherectomy Cohort — Chris Owens, M.D.      

9:34 AM — Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial 
— John Laird, M.D.

9:44 AM — Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial — Ido Weinberg, M.D.   

9:54 AM — Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial  — John Laird, M.D.   

10:04 AM — PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery  — Richard Saxon, M.D. 

 

For more information: vivaphysicians.org/annual-conference/viva-16/

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init